scholarly journals A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice

2020 ◽  
Vol 22 (5) ◽  
pp. 873-878 ◽  
Author(s):  
Giorgio Sesti ◽  
Lars Bardtrum ◽  
Selcuk Dagdelen ◽  
Natalie Halladin ◽  
Martin Haluzík ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Practice ◽  
Insulin Glargine ◽  
Randomized Trial ◽  
Insulin Degludec ◽  
Treatment Targets

P21 Effect of insulin degludec vs insulin glargine in a one-year randomized trial in insulin-naïve patients with type 2 diabetes

2013 ◽  
Vol 7 (1) ◽  
pp. 81
Author(s):  
A. Rana ◽  
B. Zinman ◽  
A. Philis-Tsimikas ◽  
Y. Handelsman ◽  
H.W. Rodbard ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Randomized Trial ◽  
Insulin Degludec ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document